From TMF Bottleneck to Seamless Flow: Interoperability in Action

At Arkivum’s recent ArkFest 2026 online event, PHARMASEAL Chief Product Officer Ricky Lakhani explored why the future of Trial Master File (TMF) management isn’t about storing more documents—it’s about connecting clinical systems to create a continuously evolving source of truth for every clinical trial.

As clinical trials become increasingly complex, disconnected technologies, manual document handling and fragmented data create unnecessary delays, increased compliance risk and additional pressure on study teams. This presentation demonstrates how interoperability is transforming the eTMF from a passive repository into an intelligent, connected ecosystem that supports real-time oversight, stronger governance and inspection readiness throughout the study lifecycle.

Watch the Presentation

What you’ll learn

In this session, Ricky discusses:

• Why the traditional eTMF model is no longer sufficient for modern clinical trials.
• How interoperability enables seamless connectivity between eTMF, CTMS, EDC, eISF, QMS, IRT, LMS, Safety systems and other critical clinical applications.
• Why regulators are increasingly assessing the integrity of connected processes and system governance—not simply the documents themselves.
• How standards such as the CDISC TMF Reference Model, modern APIs and the Exchange Mechanism Specification (EMS) provide the foundation for secure, scalable clinical system integration.
• How artificial intelligence can automate classification, metadata extraction and quality control while allowing TMF professionals to focus on higher-value oversight.
• Why organisations should begin designing archive-ready clinical ecosystems from study start rather than treating archiving as a project at study close.

Key Takeaways

The session challenges organisations to rethink the role of the TMF.

Rather than acting as a retrospective filing cabinet, the modern eTMF should become the operational heartbeat of the clinical trial—continuously synchronising information from connected systems, providing real-time visibility into study health and supporting proactive risk management. Interoperability enables sponsors and CROs to eliminate manual reconciliation, improve data integrity and create a single source of truth across the clinical technology landscape.

Ricky also explores the practical foundations required to achieve this vision, including open APIs, standardised metadata, EMS-compliant data exchange and intelligent automation. Together, these capabilities enable organisations to reduce administrative burden, improve inspection readiness and build flexible technology ecosystems that can evolve alongside changing clinical development needs.

About Ricky

Ricky Lakhani is Chief Product Officer at PHARMASEAL and leads the strategic development of the Engility® clinical trial management platform. With more than 20 years’ experience across organisations including Amgen, Roche and Medidata, Ricky specialises in clinical trial technology, interoperability, unified digital architectures and the integration of eTMF, CTMS and archival solutions.